Monitor and Prevent Antimicrobial Resistance in Kenya (MAP-AMR)
Detecting and Controlling Candida auris and Invasive Candida Infections in Selected Kenyan Hospitals
Strengthening surveillance, institutional preparedness, and clinical response capacity for Candida auris and invasive Candida infections in selected Kenyan hospitals through awareness, detection protocols, and infection prevention interventions.
Project Background
Kenyan hospitals faced a major gap in systematic surveillance and clinical management protocols for Candida auris and other invasive Candida infections. The absence of effective detection systems, limited awareness among healthcare workers, and weak institutional preparedness posed significant patient safety risks.
Immunocompromised patients were especially vulnerable to invasive fungal infections, while delayed diagnosis and inadequate infection prevention systems increased the risk of transmission within healthcare facilities.
The project was initiated to strengthen institutional response capacity, improve fungal infection surveillance, and support early detection and management of Candida auris infections in selected Kenyan hospitals.
Project Statistics
2023-2026
Project Duration
20+
Healthcare Workers Trained
1
Lead Hospital Site
3
Key AMR Focus Areas
Project Objectives
Detection & Surveillance
Detect and monitor Candida auris and invasive Candida infections in selected Kenyan hospitals.
Institutional Capacity
Strengthen hospital preparedness and response capacity for invasive fungal infections.
Clinical Awareness
Improve awareness and clinical management practices among healthcare workers.
Infection Prevention
Enhance institutional infection prevention and control measures in healthcare settings.
Key Interventions
- Sensitization and awareness campaigns on Candida infections
- Establishment of Candida auris detection protocols
- Strengthening microbiology diagnostic utilization
- Institutional infection prevention and control measures
- Healthcare worker capacity building and mentorship
- Hospital-based surveillance and reporting systems
- Coordination between laboratory and clinical teams
- Data collection, monitoring, and reporting
Leadership & Responsibilities
Position
Co-Investigator and Site Lead
Partners
MAP-AMR, CDC, Ministry of Health (MOH)
Led site-level implementation activities
Sensitized clinical staff on Candida auris detection and management
Coordinated with laboratory teams for improved diagnostic utilization
Conducted surveillance data collection and reporting
AMR Intervention Areas
Major Achievements & Institutional Impact
Healthcare Worker Sensitization
Successfully sensitized over 20 clinicians, nurses, and laboratory personnel on Candida auris detection, management, and surveillance.
Improved Diagnostics
Strengthened microbiology utilization and improved laboratory coordination for invasive fungal infection diagnosis.
Institutional Readiness
Improved institutional preparedness for invasive fungal infection surveillance and response at Machakos Level 5 Hospital.
Enhanced IPC Measures
Supported implementation of infection prevention and control interventions to reduce hospital-associated fungal infection risks.
@2026 One Health Antimicrobial Resistance Network (OHAAN). All rights reserved.